On Wednesday, May 26, 2021, at 10:00 a.m. Eastern, the Federal COVID-19 Response Team will host a Facebook Live event focusing on the updated National Institutes of Health guidance on Monoclonal Antibodies (mAbs). The event will feature Dr. H. Clifford Lane (NIH), Dr. Raj Gandhi (Harvard), and Ms. Cecily Waters (US Department of Health and Human Services), who will discuss the updated recommendations from the NIH COVID-19 Treatment Guidelines Panel.
You may remember we previously sent information about monoclonal antibody treatments, which were approved earlier this year by the Food and Drug Administration (FDA) for emergency use to treat people with mild to moderate COVID-19. Those approvals have since been revised by the FDA to expand the list of conditions that place people with mild to moderate COVID-19 at increased risk for disease progression. This webinar will address that revision and the updated NIH guidance.
To participate, visit www.facebook.com/CombatCOVIDgov. The event will have captions. If you have any questions, you can contact [email protected].
You can also find more information about this and other updates at CombatCOVID.hhs.gov.
